Immune checkpoint pathways, such as the programmed death receptor-1 and programmed death ligand-1 (PD-1/PD-L1) signaling pathway, are crucial for the regulation of immune self-tolerance that can be employed by cancer cells to avoid immune surveillance. The gene discussed is PDCD1; the disease is cancer.